CRINETICS PHARMACEUTICALS IN's ticker is CRNX and the CUSIP is 22663K107. A total of 84 filers reported holding CRINETICS PHARMACEUTICALS IN in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,199,355 | +67.6% | 40,328 | +1.6% | 0.01% | +66.7% |
| Q2 2023 | $715,574 | +25.4% | 39,710 | +11.8% | 0.01% | +20.0% |
| Q1 2023 | $570,451 | -14.5% | 35,520 | -2.6% | 0.01% | -16.7% |
| Q4 2022 | $667,529 | +15.9% | 36,477 | +24.4% | 0.01% | +20.0% |
| Q3 2022 | $576,000 | -2.7% | 29,326 | -7.6% | 0.01% | -16.7% |
| Q2 2022 | $592,000 | -44.7% | 31,740 | -35.0% | 0.01% | -50.0% |
| Q1 2022 | $1,071,000 | -31.4% | 48,815 | -11.2% | 0.01% | -33.3% |
| Q4 2021 | $1,562,000 | +56.4% | 54,964 | +15.9% | 0.02% | +80.0% |
| Q3 2021 | $999,000 | +7.1% | 47,436 | -4.2% | 0.01% | +25.0% |
| Q2 2021 | $933,000 | +2.5% | 49,516 | -16.9% | 0.01% | -11.1% |
| Q1 2021 | $910,000 | +8.5% | 59,563 | +0.2% | 0.01% | 0.0% |
| Q4 2020 | $839,000 | +27.7% | 59,437 | +41.7% | 0.01% | -10.0% |
| Q3 2020 | $657,000 | -16.3% | 41,934 | -6.4% | 0.01% | -9.1% |
| Q2 2020 | $785,000 | +21.3% | 44,809 | +1.7% | 0.01% | +10.0% |
| Q1 2020 | $647,000 | -47.6% | 44,040 | -10.4% | 0.01% | 0.0% |
| Q4 2019 | $1,234,000 | +70.2% | 49,172 | +2.0% | 0.01% | +66.7% |
| Q3 2019 | $725,000 | -42.6% | 48,217 | -4.6% | 0.01% | -33.3% |
| Q2 2019 | $1,263,000 | – | 50,525 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Versant Venture Management, LLC | 2,030,616 | $31,028,000 | 6.04% |
| 5AM Venture Management, LLC | 1,362,286 | $20,816,000 | 3.75% |
| Burrage Capital Management LLC | 272,393 | $4,162,000 | 3.37% |
| Altium Capital Management LP | 361,930 | $5,530,000 | 1.54% |
| Vivo Capital, LLC | 2,214,138 | $33,832,000 | 1.19% |
| Bain Capital Life Sciences Investors, LLC | 1,071,428 | $16,371,000 | 0.93% |
| Perceptive Advisors | 3,659,381 | $51,606,000 | 0.65% |
| New Leaf Venture Partners, L.L.C. | 141,000 | $2,154,000 | 0.50% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 2,003,688 | $30,616,000 | 0.45% |
| Opaleye Management Inc. | 188,000 | $2,873,000 | 0.42% |